Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, WAVE Life Sciences Ltd maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -327.44%, while the net margin is -308.37%. These profitability ratios, combined with a Return on Equity (ROE) of -56.16%, provide a clear picture of how effectively WVE converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, WVE competes directly with industry leaders such as RCUS and IRON. With a market capitalization of $2.61B, it holds a significant position in the sector. When comparing efficiency, WVE's gross margin of 100.00% stands against RCUS's 100.00% and IRON's N/A. Such benchmarking helps identify whether WAVE Life Sciences Ltd is trading at a premium or discount relative to its financial performance.
